Proyecto Hepacare
Selección de publicaciones
Programa de Hepatología
Argemi J, Latasa MU, Atkinson SR, Blokhin IO, Massey V, Gue JP, Cabezas J, Lozano JJ, Van Booven D, Bell A, Cao S, Vernetti LA, Arab JP, Ventura-Cots M, Edmunds LR, Fondevilla C, Stärkel P, Dubuquoy L, Louvet A, Odena G, Gomez JL, Aragon T, Altamirano J, Caballeria J, Jurczak MJ, Taylor DL, Berasain C, Wahlestedt C, Monga SP, Morgan MY, Sancho-Bru P, Mathurin P, Furuya S, Lackner C, Rusyn I, Shah VH, Thursz MR, Mann J, Avila MA, Bataller R.
Nat Commun. 2019 Jul 16;10(1):3126. doi: 10.1038/s41467-019-11004-3.
PMID:31311938
> Chromatin dynamics during liver regeneration
Arechederra M, Berasain C, Avila MA, Fernández-Barrena MG.
Semin Cell Dev Biol. 2019 Apr 9. pii: S1084-9521(18)30193-9. doi: 10.1016/j.semcdb.2019.03.004. [Epub ahead of print] Review.
PMID:30940574
> Splicing events in the control of genome integrity: role of SLU7 and truncated SRSF3 proteins
Jiménez M, Urtasun R, Elizalde M, Azkona M, Latasa MU, Uriarte I, Arechederra M, Alignani D, Bárcena-Varela M, Álvarez-Sola G, Colyn L, Santamaría E, Sangro B, Rodriguez-Ortigosa C, Fernández-Barrena MG, Ávila MA, Berasain C.
Nucleic Acids Res. 2019 Apr 23;47(7):3450-3466. doi: 10.1093/nar/gkz014.
PMID:30657957
Santamaría E, Rodríguez-Ortigosa CM, Uriarte I, Latasa MU, Urtasun R, Alvarez-Sola G, Bárcena-Varela M, Colyn L, Arcelus S, Jiménez M, Deutschmann K, Peleteiro-Vigil A, Gómez-Cambronero J, Milkiewicz M, Milkiewicz P, Sangro B, Keitel V, Monte MJ, Marin JJG, Fernández-Barrena MG, Ávila MA, Berasain C.
Hepatology. 2019 Apr;69(4):1632-1647. doi: 10.1002/hep.30348. Epub 2019 Mar 4.
PMID:30411380
Bárcena-Varela M, Caruso S, Llerena S, Álvarez-Sola G, Uriarte I, Latasa MU, Urtasun R, Rebouissou S, Alvarez L, Jimenez M, Santamaría E, Rodriguez-Ortigosa C, Mazza G, Rombouts K, San José-Eneriz E, Rabal O, Agirre X, Iraburu M, Santos-Laso A, Banales JM, Zucman-Rossi J, Prósper F, Oyarzabal J, Berasain C, Ávila MA, Fernández-Barrena MG.
Hepatology. 2019 Feb;69(2):587-603. doi: 10.1002/hep.30168. Epub 2019 Jan 4.
PMID:30014490
Jimenez M, Arechederra M, Ávila MA, Berasain C.
Transl Gastroenterol Hepatol. 2018 Oct 31;3:84. doi: 10.21037/tgh.2018.10.11. eCollection 2018. Review.
PMID:30505971
> Fibroblast growth factors 19 and 21 in acute liver damage
Shan Z, Alvarez-Sola G, Uriarte I, Arechederra M, Fernández-Barrena MG, Berasain C, Ju C, Avila MA.
Ann Transl Med. 2018 Jun;6(12):257. doi: 10.21037/atm.2018.05.26. Review.
PMID:30069459
Selección de publicaciones
Programa de Inmunología e Inmunoterapia
> Getting insights into hepatocellular carcinoma tumour heterogeneity by multiomics dissection”
Sarobe P, Corrales F.
Gut. 2019 Nov;68(11):1913-1914.
> When Cancer Vaccines Go Viral
Repáraz D, Llopiz D, Sarobe P.
Clin Cancer Res. 2019 Aug 15;25(16):4871-4873.
> Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model
Llopiz D, Ruiz M, Villanueva L, Iglesias T, Silva L, Egea J, Lasarte JJ, Pivette P, Trochon-Joseph V, Vasseur B, Dixon G, Sangro B, Sarobe P.
Cancer Immunol Immunother. 2019 Mar;68(3):379-393.
> Enhancement of Antitumor Vaccination by Targeting Dendritic Cell-Related
IL-10
Llopiz D, Ruiz M, Silva L, Sarobe P.
Front Immunol. 2018 Sep 3;9:1923.
> Therapeutic Effect of Irreversible Electroporation in Combination with Poly-ICLC Adjuvant in Preclinical Models of Hepatocellular Carcinoma
Vivas I, Iribarren K, Lozano T, Cano D, Lasarte-Cia A, Chocarro S, Gorraiz M, Sarobe P, Hervás-Stubbs S, Bilbao JI, Casares N, Lasarte JJ.
J Vasc Interv Radiol. 2019 Jul;30(7):1098-1105. DOI:10.1016/j.jvir.2019.02.023.
> Blockage of FOXP3 transcription factor dimerization and FOXP3/AML1 interaction inhibits T regulatory cell activity: sequence optimization of a peptide inhibitor.
Lozano T, Gorraiz M, Lasarte-Cía A, Ruiz M, Rabal O, Oyarzabal J, Hervás-Stubbs S, Llopiz D, Sarobe P, Prieto J, Casares N, Lasarte JJ.
Oncotarget. 2017 May 13;8(42):71709-71724. doi: 10.18632/oncotarget.17845.
> Targeting the anion exchanger 2 with specific peptides as a new therapeutic approach in B lymphoid neoplasms.
Celay J, Lozano T, Concepcion AR, Beltrán E, Rudilla F, García-Barchino MJ, Robles EF, Rabal O, de Miguel I, Panizo C, Casares N, Oyarzabal J, Prieto J, Medina JF, Lasarte JJ, Martínez-Climent JÁ.
Haematologica. 2018 Jun;103(6):1065-1072. doi: 10.3324/haematol.2017.175687.
> Genetic modification of CD8 + T cells to express EGFR: potential application for adoptive T cell therapies. Running title: EGFR-CD8 + T-cells for ACT.
Teresa Lozano,Silvia Chocarro, Celia Martin, Aritz Lasarte-Cía, Cyntia Del Valle, Marta Gorraiz, Patricia Sarrión, Marina Ruiz, Amaia Lujambio, Sandra Hervas Stubbs, Pablo Sarobe, Noelia Casares and Juan José Lasarte.
Frontiers in Immunology, 2020, In press.